These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8270584)

  • 21. Economic cost of Guillain-Barré syndrome in the United States.
    Frenzen PD
    Neurology; 2008 Jul; 71(1):21-7. PubMed ID: 18591502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient preferences for depression treatment programs and willingness to pay for treatment.
    Morey E; Thacher JA; Craighead WE
    J Ment Health Policy Econ; 2007 Jun; 10(2):73-85. PubMed ID: 17603148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The annual impact of seasonal influenza in the US: measuring disease burden and costs.
    Molinari NA; Ortega-Sanchez IR; Messonnier ML; Thompson WW; Wortley PM; Weintraub E; Bridges CB
    Vaccine; 2007 Jun; 25(27):5086-96. PubMed ID: 17544181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of coronary heart disease in New Zealand.
    Scott WG; White HD; Scott HM
    N Z Med J; 1993 Aug; 106(962):347-9. PubMed ID: 8255558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased medical costs of a population-based sample of depressed elderly patients.
    Katon WJ; Lin E; Russo J; Unutzer J
    Arch Gen Psychiatry; 2003 Sep; 60(9):897-903. PubMed ID: 12963671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-based structural models of health care costs: alcohol use, physical health, mental health, and functioning.
    Green CA; Polen MR; Perrin NA; Leo M; Lynch FL; Rush DP
    J Ment Health Policy Econ; 2004 Sep; 7(3):107-25. PubMed ID: 15478990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generalized anxiety disorder: prevalence, burden, and cost to society.
    Wittchen HU
    Depress Anxiety; 2002; 16(4):162-71. PubMed ID: 12497648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opportunities for cost-effective prevention of late-life depression: an epidemiological approach.
    Smit F; Ederveen A; Cuijpers P; Deeg D; Beekman A
    Arch Gen Psychiatry; 2006 Mar; 63(3):290-6. PubMed ID: 16520434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?
    Davidson JR; Meltzer-Brody SE
    J Clin Psychiatry; 1999; 60 Suppl 7():4-9; discussion 10-1. PubMed ID: 10326869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The costs of treating depression.
    Santiago JM
    J Clin Psychiatry; 1993 Nov; 54(11):425-6. PubMed ID: 8270585
    [No Abstract]   [Full Text] [Related]  

  • 35. Indirect cost of ischemic heart disease to employers.
    Guico-Pabia CJ; Murray JF; Teutsch SM; Wertheimer AI; Berger ML
    Am J Manag Care; 2001 Jan; 7(1):27-34. PubMed ID: 11209448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic consequences of HIV/AIDS in India.
    Pandav CS; Anand K; Shamanna BR; Chowdhury S; Nath LM
    Natl Med J India; 1997; 10(1):27-30. PubMed ID: 9069706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of primary care depression intervention on employment and workplace conflict outcomes: is value added?
    Smith JL; Rost KM; Nutting PA; Libby AM; Elliott CE; Pyne JM
    J Ment Health Policy Econ; 2002 Mar; 5(1):43-9. PubMed ID: 12529569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiology of anxiety disorders: prevalence and societal costs.
    Lépine JP
    J Clin Psychiatry; 2002; 63 Suppl 14():4-8. PubMed ID: 12562112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Workplace costs associated with acute exacerbation of chronic bronchitis: a comparison of moxifloxacin and levofloxacin.
    Li-McLeod J; Perfetto EM
    Manag Care Interface; 2001 Feb; 14(2):52-9. PubMed ID: 11228817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic effects of insomnia.
    Stoller MK
    Clin Ther; 1994; 16(5):873-97; discussion 854. PubMed ID: 7859246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.